YON PARK

Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology TAMPA, FL NPI 1689601239

General Payments — all program years on this page

$1,419.29

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 68
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $460.87 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $460.8722

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $100.247
2019 $87.881
2020 $22.742
2021 $25.262
2022 $231.3813
2023 $490.9221
2024 $460.8722

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087340443 Novartis Pharmaceuticals Corporation $26.50 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089466470 Daiichi Sankyo Inc. $28.21 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101168100 Celgene Corporation $15.99 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101168102 Celgene Corporation $18.79 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101168106 Celgene Corporation $23.84 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101168108 Celgene Corporation $10.38 06/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101168114 Celgene Corporation $21.92 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101168124 Celgene Corporation $7.80 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101168126 Celgene Corporation $16.30 08/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101168130 Celgene Corporation $23.50 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101168132 Celgene Corporation $23.26 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101168134 Celgene Corporation $4.65 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105183628 ABBVIE INC. $17.14 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131479840 ARRAY BIOPHARMA INC $24.94 12/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131812714 ARRAY BIOPHARMA INC $23.99 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133830217 Gilead Sciences, Inc. $24.04 06/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133830219 Gilead Sciences, Inc. $22.75 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133830221 Gilead Sciences, Inc. $22.46 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133830223 Gilead Sciences, Inc. $22.52 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137934517 TAIHO ONCOLOGY, INC. $14.27 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144964735 Takeda Pharmaceuticals U.S.A., Inc. $33.33 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144964737 Takeda Pharmaceuticals U.S.A., Inc. $34.29 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.